Fidson Healthcare Audited FY 2024
In today's tales, i walk through Fidson Healthcare's audited FY 2024 results.
The pharma is an often overlooked one by investors, but it hold lots of potential.
The key point for me in these numbers are the margins in the different drug segments.
Pardon the slightly worn out voice. I had just come off a video shoot.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.